Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities (2016 - 2025)

Prestige Consumer Healthcare has reported Total Non-Current Liabilities over the past 13 years, most recently at $1.7 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 8.04% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 8.04%, while the annual FY2025 figure was $1.6 billion, 5.57% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $1.7 billion at Prestige Consumer Healthcare, up from $1.6 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $2.2 billion in Q3 2021 and troughed at $1.5 billion in Q4 2024.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 15.76% in 2023 and later grew 8.04% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $2.1 billion in 2021, then decreased by 3.69% to $2.1 billion in 2022, then decreased by 15.76% to $1.7 billion in 2023, then fell by 11.23% to $1.5 billion in 2024, then increased by 8.04% to $1.7 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for PBH at $1.7 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.